Cara Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing new chemical entities.
Read More
KALY has a U.S. Patented Cannabis Extraction Process and is developing treatments for various medical conditions.
Read More
This Notice of Allowance is a continuation of AXIM’s patent (US 10,092,538 B2) granted to the Company in October 2018.
Read More
The company expects to report topline data from the study in the summer of 2020.
Read More![CURE Pharmaceutical [OTCQB:CURR] Takes First Step to Acquire Coeptis Pharmaceuticals and its Combination Drug for Osteoarthritis Pain and Hypertension](https://www.investinweed.com/wp-content/uploads/Cure-Pharmaceutical-627x376.png)
The planned acquisition has the potential to accelerate its 505(b)(2) drug pipeline and expedite its growth with a planned 2020 launch of Consensi.
Read More
Get stock alerts, news & related alerts straight to your inbox!